Kelly R. Thornburg
Corporate Officer/Principal bei CHIMERIC THERAPEUTICS LIMITED
Profil
Kelly R.
Thornburg is currently the Vice President & Head-Quality at Chimeric Therapeutics Ltd.
(Australia) since 2022.
Previously, Thornburg worked as an Executive Director-Quality at Amgen, Inc. and as the Head-US Commercial Manufacturing at Kite Pharma, Inc. Thornburg also served as the Senior Vice President-Operations at XBiotech, Inc. from 2015 to 2017.
Thornburg obtained an undergraduate degree from Rockhurst University.
Aktive Positionen von Kelly R. Thornburg
| Unternehmen | Position | Beginn |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03.02.2022 |
Ehemalige bekannte Positionen von Kelly R. Thornburg
| Unternehmen | Position | Ende |
|---|---|---|
| XBIOTECH INC. | Chief Operating Officer | 05.05.2017 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Ausbildung von Kelly R. Thornburg
| Rockhurst University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| XBIOTECH INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
